Rituximab Plus Venetoclax in Combination With Zandelisib in Subjects With CLL
Clinical trial NCT05209308 · WITHDRAWN
Trial details
- NCT number
- NCT05209308
- Sponsor
- MEI Pharma, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2023-03-15
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.